Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Syqe Medical

Syqe Medical
2011 FOUNDED
PRIVATE STATUS
91-100 EMPLOYEES
PE Growth LATEST DEAL TYPE
5 FINANCING ROUNDS
Description

Developer of pocket-sized metered-dose cannabis inhaler designed to allow patients to reach the optimum balance between symptom relief and psycho-activities. The company's cannabis inhaler transforms psychoactive botanical into mainstream medical drugs and utilizes selective 100-microgram dosing precision, real-time thermal and flow controllers, lung interfacing and inhalation-based drug delivery platform, enabling patients to recover diseases and regaining their quality of life.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Jaffa
  • Tel Aviv 6816914
  • Israel

+972 00-000-0000

Syqe Medical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Syqe Medical‘s full profile, request access.

Request full access to PitchBook

Syqe Medical Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Syqe Medical‘s full profile, request access.

Request full access to PitchBook

Syqe Medical Executive Team (9)

Name Title Board
Seat
Contact
Info
Perry Davidson Co-Founder & Chief Executive Officer
Revital Rodovsky Chief Financial Officer
Seth Kindler MD Chief Science Officer
James Amihood Chief Business Officer
Daniella Atzmony Chief Intellectual Property Officer

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »

Syqe Medical Board Members (2)

Name Representing Role Since Contact
Info
00000 000000 Syqe Medical Co-Founder & Board Member 000 0000
00000 0000 00 Syqe Medical Chairman 000 0000